These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 694830)

  • 1. Effect of hydrocortisone on the elimination of fibrin from the pulmonary vessels in the rat.
    Diffang C; Saldeen T
    Thromb Res; 1978 Jul; 13(1):25-36. PubMed ID: 694830
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of brinase (protease I from aspergillus oryzae) on the elimination of fibrin from the lungs and pulmonary damage in rats with induced intravascular coagulation and inhibited fibrinolysis.
    Diffang C; Saldeen T
    Thromb Res; 1976 Dec; 9(6):611-22. PubMed ID: 1006629
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibitory effect of dextran 40 upon thrombin-induced fibrin deposition in rat lungs.
    Diffang C; Rammer L; Saldeen T
    Ups J Med Sci; 1976; 81(1):23-7. PubMed ID: 1273996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deposition and clearance of fibrin in the rat lung following acute haemorrhage.
    Gerdin B; Saldeen T
    Circ Shock; 1979; 6(4):357-64. PubMed ID: 535139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of alpha-receptor blockade on the rate of fibrin elimination from the rat lung.
    Gerdin B; Diffang C; Saldeen T
    Circ Shock; 1980; 7(1):93-101. PubMed ID: 6104545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative monitoring of intravascular coagulation and fibrinolysis in the lungs of rats.
    Coombey D; Tyler HM
    Thromb Diath Haemorrh; 1972 Apr; 27(2):241-5. PubMed ID: 5049613
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of N-acetylcysteine on fibrin deposition in the rat lung due to intravascular coagulation.
    Wegener T; Wallin R; Saldeen T
    Ups J Med Sci; 1986; 91(1):45-52. PubMed ID: 3716022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated thrombin-activatable fibrinolysis inhibitor attenuates spontaneous fibrinolysis of batroxobin-induced fibrin deposition in rat lungs.
    Wu C; Dong N; da Cunha V; Martin-McNulty B; Tran K; Nagashima M; Wu Q; Morser J; Wang YX
    Thromb Haemost; 2003 Sep; 90(3):414-21. PubMed ID: 12958609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerular fibrinolytic activity after thrombin perfusion in the rat.
    Sraer JD; Delarue F; Dard S; De Seigneux R; Morel-Maroger L; Kanfer A
    Lab Invest; 1975 Apr; 32(4):515-7. PubMed ID: 123973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of total cavo-portal shunt on pulmonary fibrin deposition after intra-aortal infusion of thrombin in the dog.
    Busch C; Saldeen T; Thorén L
    Acta Chir Scand; 1975; 141(6):455-60. PubMed ID: 1189849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacologic influence on secondary generalized fibrinolysis].
    Markwardt F; Drawert J; Perlewitz J
    Acta Biol Med Ger; 1979; 38(8):1201-9. PubMed ID: 532498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early postischaemic renal fibrin deposition and reduction of glomerular filtration rate in the rat: effect of the defibrinating agent Arwin.
    Losonczy G
    Acta Physiol Hung; 1985; 66(2):183-7. PubMed ID: 4050462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental studies on the significance of existing vascular changes in the agglomeration of fibrin].
    Studer A; Lorez HP
    Pathol Microbiol (Basel); 1966; 29(4):406-13. PubMed ID: 5924734
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanism of inhibition of fibrinolysis and fibrinogenolysis by the end fibrinogen degradation products.
    Khavkina LS; Rozenfeld MA; Leonova VB
    Thromb Res; 1995 Apr; 78(2):173-87. PubMed ID: 7482434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin-induced lung vascular injury. Roles of fibrinogen and fibrinolysis.
    Johnson A; Tahamont MV; Malik AB
    Am Rev Respir Dis; 1983 Jul; 128(1):38-44. PubMed ID: 6870068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interference of lysed fibrin with coagulation: a quantifying approach using isotopic techniques.
    Regoeczi E
    Br J Haematol; 1971 Aug; 21(2):209-18. PubMed ID: 4934606
    [No Abstract]   [Full Text] [Related]  

  • 17. The clearance of 125I-labelled fibrin from the subcutaneous tissue of limbs with lipodermatosclerosis.
    Leach RD; Browse NL
    Br J Surg; 1986 Jun; 73(6):465-8. PubMed ID: 3719273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subunits and susceptibility of fibrins formed from bovine fibrinogen by arvin, reptilase, thrombin and staphylothrombin.
    Zajdel M; Wegrzynowicz Z; Sawecka J; Kopeć M
    Thromb Res; 1975 Apr; 6(4):337-44. PubMed ID: 1169826
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fibrinogen-fibrin derivatives during difibrase therapy. Detection and course observations of high-molecular and low-molecular derivatives using agarose gel filtration].
    Asbeck F; Lechler E; van de Loo J
    Verh Dtsch Ges Inn Med; 1974; 80():1466-70. PubMed ID: 4454459
    [No Abstract]   [Full Text] [Related]  

  • 20. Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation.
    Gresele P; Momi S; Berrettini M; Nenci GG; Schwarz HP; Semeraro N; Colucci M
    J Clin Invest; 1998 Feb; 101(3):667-76. PubMed ID: 9449701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.